These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 499300)

  • 1. Pharmacokinetics of cephacetrile in patients undergoing haemodialysis.
    Dominguez-Gil A; Lanao JM; Tabernero JM; Rodriguez Commes JL; de Castro S
    Eur J Clin Pharmacol; 1979 Aug; 16(1):49-52. PubMed ID: 499300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Tabernero JM; Rubio F
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):416-20. PubMed ID: 500264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):357-60. PubMed ID: 489203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefoxitin in patients undergoing hemodialysis.
    Garcia MJ; Dominguez-Gil A; Tabernero JM; Bondia Román A
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):366-70. PubMed ID: 489205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cephacetrile--application of pharmacokinetic data to dosage determination.
    Brogard JM; Dorner M; Brandt C; Lavillaureix J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):168-76. PubMed ID: 950258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceforanide pharmacokinetics in haemodialysis: the effect of ultrafiltration.
    Lanao JM; de Prada CR; Dominguez-Gil A; Tabernero JM; Martín J; Gómez JR
    Biopharm Drug Dispos; 1986; 7(4):335-46. PubMed ID: 3768489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefoxitin in patients with normal or impaired renal function.
    Garcia MJ; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Eur J Clin Pharmacol; 1979 Sep; 16(2):119-24. PubMed ID: 499308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of cefroxadine (CGP-9000) from patients undergoing dialysis.
    Nieto MJ; Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
    Eur J Clin Pharmacol; 1983; 24(1):109-12. PubMed ID: 6832192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiological assessment of the concentration of cephacetrile in plasma and cancellous bone of femoral heads.
    Stuflesser H; Walker N; Meyer-Brunot HG; Theobald W
    J Antimicrob Chemother; 1978 Mar; 4(2):188. PubMed ID: 649541
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cephacetrile. Studies on absorption excretion and diffusion into heart (author's transl)].
    Shibuya H; Miyawaki J; Matsuyoshi T; Anai K; Kawano Y; Onimura S; Takizawa S; Akaiwa H; Asao M
    Jpn J Antibiot; 1980 Oct; 33(10):1138-44. PubMed ID: 7206218
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of cefamandole in rabbits with experimentally induced renal impairment.
    Campillo JA; Dominguez-Gil AA; Cepeda M; Dominguez-Gil A
    J Antibiot (Tokyo); 1980 Mar; 33(3):322-7. PubMed ID: 7380743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP
    Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of cephacetrile after parenteral administration in rats and rabbits.
    Nakai Y; Kanai Y; Fugono T; Tanayama S
    J Antibiot (Tokyo); 1976 Jan; 29(1):81-90. PubMed ID: 931795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics.
    Nissenson AR; Levin NW; Parker RH
    Clin Pharmacol Ther; 1972; 13(6):887-94. PubMed ID: 5081601
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine after intravenous administration.
    Bergan T
    Chemotherapy; 1977; 23(6):389-404. PubMed ID: 923329
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of cefazolin in patients with renal failure; special reference to hemodialysis.
    Brogard JM; Pinget M; Brandt C; Lavillaureix J
    J Clin Pharmacol; 1977 Apr; 17(4):225-30. PubMed ID: 849996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J; Francke EL; Saltzman M; Neu HC
    Ther Drug Monit; 1981; 3(1):71-4. PubMed ID: 6262952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of a new cephalosporin, cephacetrile, as a function of renal excretion capacity].
    Brogard JM; Ruscher H; Frankhauser J; Kuntzmann F; Lavillaureix J
    Pathol Biol (Paris); 1973 Jun; 21(6):671-9. PubMed ID: 4581199
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of pantoprazole in patients with end-stage renal failure.
    Kliem V; Bahlmann J; Hartmann M; Huber R; Lühmann R; Wurst W
    Nephrol Dial Transplant; 1998 May; 13(5):1189-93. PubMed ID: 9623552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.